Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 19566678)

1.

Polyglutamine expansion in huntingtin alters its interaction with phospholipids.

Kegel KB, Sapp E, Alexander J, Valencia A, Reeves P, Li X, Masso N, Sobin L, Aronin N, DiFiglia M.

J Neurochem. 2009 Sep;110(5):1585-97. doi: 10.1111/j.1471-4159.2009.06255.x. Epub 2009 Jun 29.

PMID:
19566678
2.

Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.

Valencia A, Reeves PB, Sapp E, Li X, Alexander J, Kegel KB, Chase K, Aronin N, DiFiglia M.

J Neurosci Res. 2010 Jan;88(1):179-90. doi: 10.1002/jnr.22184.

PMID:
19642201
3.

Interaction of huntingtin fragments with brain membranes--clues to early dysfunction in Huntington's disease.

Suopanki J, Götz C, Lutsch G, Schiller J, Harjes P, Herrmann A, Wanker EE.

J Neurochem. 2006 Feb;96(3):870-84. Epub 2006 Jan 9.

PMID:
16405500
4.

Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.

Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM.

Proc Natl Acad Sci U S A. 1996 May 14;93(10):5037-42.

5.

Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.

Huang CC, Faber PW, Persichetti F, Mittal V, Vonsattel JP, MacDonald ME, Gusella JF.

Somat Cell Mol Genet. 1998 Jul;24(4):217-33.

PMID:
10410676
6.

Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways.

Velier J, Kim M, Schwarz C, Kim TW, Sapp E, Chase K, Aronin N, DiFiglia M.

Exp Neurol. 1998 Jul;152(1):34-40.

PMID:
9682010
7.

Interaction of Huntington disease protein with transcriptional activator Sp1.

Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H, Li XJ.

Mol Cell Biol. 2002 Mar;22(5):1277-87.

8.

Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.

Smith R, Bacos K, Fedele V, Soulet D, Walz HA, Obermüller S, Lindqvist A, Björkqvist M, Klein P, Onnerfjord P, Brundin P, Mulder H, Li JY.

Hum Mol Genet. 2009 Oct 15;18(20):3942-54. doi: 10.1093/hmg/ddp336. Epub 2009 Jul 23.

9.

Interaction of the nuclear matrix protein NAKAP with HypA and huntingtin: implications for nuclear toxicity in Huntington's disease pathogenesis.

Sayer JA, Manczak M, Akileswaran L, Reddy PH, Coghlan VM.

Neuromolecular Med. 2005;7(4):297-310.

PMID:
16391387
10.

Molecular aspects of Huntington's disease.

Walling HW, Baldassare JJ, Westfall TC.

J Neurosci Res. 1998 Nov 1;54(3):301-8. Review.

PMID:
9819135
11.

Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin.

Cyr M, Sotnikova TD, Gainetdinov RR, Caron MG.

FASEB J. 2006 Dec;20(14):2541-3. Epub 2006 Oct 25.

12.
13.

Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells.

Chun W, Lesort M, Tucholski J, Faber PW, MacDonald ME, Ross CA, Johnson GV.

Neurobiol Dis. 2001 Jun;8(3):391-404.

PMID:
11442349
14.

Polyglutamine expansion in huntingtin increases its insertion into lipid bilayers.

Kegel KB, Schewkunow V, Sapp E, Masso N, Wanker EE, DiFiglia M, Goldmann WH.

Biochem Biophys Res Commun. 2009 Sep 25;387(3):472-5. doi: 10.1016/j.bbrc.2009.07.039. Epub 2009 Jul 14.

PMID:
19607813
15.

Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.

Nguyen T, Hamby A, Massa SM.

Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11840-5. Epub 2005 Aug 8.

16.

Effects of overexpression of huntingtin proteins on mitochondrial integrity.

Wang H, Lim PJ, Karbowski M, Monteiro MJ.

Hum Mol Genet. 2009 Feb 15;18(4):737-52. doi: 10.1093/hmg/ddn404. Epub 2008 Nov 27.

17.

Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease.

Li SH, Yu ZX, Li CL, Nguyen HP, Zhou YX, Deng C, Li XJ.

J Neurosci. 2003 Jul 30;23(17):6956-64.

18.

Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism.

del Toro D, Canals JM, Ginés S, Kojima M, Egea G, Alberch J.

J Neurosci. 2006 Dec 6;26(49):12748-57.

19.

Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.

Busch A, Engemann S, Lurz R, Okazawa H, Lehrach H, Wanker EE.

J Biol Chem. 2003 Oct 17;278(42):41452-61. Epub 2003 Jul 29.

20.

Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity.

Cowan CM, Fan MM, Fan J, Shehadeh J, Zhang LY, Graham RK, Hayden MR, Raymond LA.

J Neurosci. 2008 Nov 26;28(48):12725-35. doi: 10.1523/JNEUROSCI.4619-08.2008.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk